Delivery Order SPE2DB20D7059-SPE2DB25FPXR3

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,639.20, is for the delivery of medical supplies, specifically MENQUADFI VIAL 0.5ML. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $13,290.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MENQUADFI VIAL 0.5ML medical products. The $1,451.56 fixed-price delivery order contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical...
This federal contract award, valued at $7,419.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $91,048.75, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The contract has a firm fixed price pricing type and a period of performance ending on November 21, 2022. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4564387961 MENQUADFI VIAL 0.5ML. The $52,597.90 fixed-price delivery order has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying pharmaceuticals and medical supplies to support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,185.96 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The award has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award, valued at $10,886.55, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of December 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,462.60 firm fixed-price delivery order contract is for the provision of MENQUADFI VIAL 0.5ML, a medical product. The contract has a period of performance through November 20, 2024 and was awarded on November 19, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,404.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of medical supplies, specifically "MENQUADFI VIAL 0.5ML", to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPXR3
    Delivery Order

The federal contract award, with ID SPE2DB20D7059|SPE2DB25FPXR3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,039.53, is a Firm Fixed Price Delivery Order for MENQUADFI VIAL 0.5ML medical supplies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. The contract supports the DLA's mission of providing medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/9/25, 9:52 AM